Immune Transcriptome and Secretome Differ between Human CD71+ Erythroid Cells from Adult Bone Marrow and Fetal Liver Parenchyma

Genes (Basel). 2022 Jul 26;13(8):1333. doi: 10.3390/genes13081333.

Abstract

CD71+ erythroid cells (CECs) were only known as erythrocyte progenitors not so long ago. In present times, however, they have been shown to be active players in immune regulation, especially in immunosuppression by the means of ROS, arginase-1 and arginase-2 production. Here, we uncover organ-of-origin differences in cytokine gene expression using NanoString and protein production using Bio-Plex between CECs from healthy human adult bone marrow and from human fetal liver parenchyma. Namely, healthy human adult bone marrow CECs both expressed and produced IFN-a, IL-1b, IL-8, IL-18 and MIF mRNA and protein, while human fetal liver parenchymaCECs expressed and produced IFN-a, IL15, IL18 and TNF-b mRNA and protein. We also detected TLR2 and TLR9 gene expression in both varieties of CECs and TLR1 and NOD2 gene expression in human fetal liver parenchymaCECs only. These observations suggest that there might be undiscovered roles in immune response for CECs.

Keywords: CD71+ erythroid cells; IL8; MIF; NOD2; TLR1; TLR2; TLR9; bone marrow; fetal liver parenchyma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Arginase*
  • Bone Marrow*
  • Erythroid Cells
  • Humans
  • Liver
  • RNA, Messenger
  • Secretome
  • Transcriptome

Substances

  • RNA, Messenger
  • Arginase

Grants and funding

This work was carried out with the support of the Russian Science Foundation, project number 21-15-00087.